Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia
- PMID: 10223955
- PMCID: PMC89262
- DOI: 10.1128/AAC.43.5.1289
Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia
Abstract
Ninety-nine Candida bloodstream isolates underwent testing for susceptibility to amphotericin B by the E test, and the results were correlated with patients' responses to amphotericin B. The MICs for isolates that were associated with therapeutic failure were significantly higher than the MICs for those associated with therapeutic success. A MIC of >/=0.38 microgram/ml identified isolates likely to be associated with therapeutic failure.
References
-
- AB BIODISK. Etest technical guide 4b: antifungal susceptibility testing of yeasts. Piscataway, N.J: AB BIODISK; 1994.
-
- Bodenhoff J. Resistance studies of Candida albicans, with special reference to two patients subjected to prolonged antimycotic treatment. Odontol Tidskr. 1968;76:279–294. - PubMed
-
- Dick J D, Rosengard B R, Merz W G, Stuart R K, Hutchins G M, Saral R. Fatal disseminated candidiasis due to amphotericin B-resistant Candida guilliermondii. Ann Intern Med. 1985;102:67–68. - PubMed
-
- Espinel-Ingroff A, Pfaller M, Erwin M E, Jones R N. Interlaboratory evaluation of Etest method for testing antifungal susceptibilities of pathogenic yeasts to five antifungal agents by using Casitone agar and solidified RPMI 1640 medium with 2% glucose. J Clin Microbiol. 1996;34:848–852. - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
